Evoke (LON:EVOK) Stock Price Down 1.5% Following Analyst Downgrade

Evoke plc (LON:EVOKGet Free Report) shares were down 1.5% during trading on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from GBX 82 to GBX 66. JPMorgan Chase & Co. currently has a neutral rating on the stock. Evoke traded as low as GBX 41.07 and last traded at GBX 41.85. Approximately 10,569,504 shares were traded during mid-day trading, an increase of 428% from the average daily volume of 2,001,332 shares. The stock had previously closed at GBX 42.50.

Several other equities research analysts also recently commented on EVOK. Berenberg Bank reaffirmed a “buy” rating and set a GBX 95 target price on shares of Evoke in a report on Thursday, August 21st. Deutsche Bank Aktiengesellschaft upped their target price on Evoke from GBX 88 to GBX 108 and gave the company a “buy” rating in a report on Wednesday, August 13th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of GBX 102.25.

Get Our Latest Report on EVOK

Evoke Price Performance

The firm has a market cap of £188.20 million, a PE ratio of -1.67 and a beta of 0.84. The business has a fifty day moving average price of GBX 51.58 and a two-hundred day moving average price of GBX 56.02.

Evoke (LON:EVOKGet Free Report) last issued its quarterly earnings results on Wednesday, August 13th. The company reported GBX 1.20 earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, sell-side analysts forecast that Evoke plc will post 12.7648305 EPS for the current fiscal year.

About Evoke

(Get Free Report)

Featured Articles

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.